Navigation Links
Eppendorf Reference Series 2000 adjustable-volume Pipette, 0.1-2.5 l

ProductsEppendorf Reference Series 2000 adjustable-volume Pipette, 0.1-2.5 l
Company Eppendorf North America
Item Eppendorf Reference Series 2000 adjustable-volume Pipette, 0.1-2.5 l
Features 
Description The Eppendorf Reference Series 2000 Pipette is a synonym for pipetting accuracy, a smooth stroke, a compact and robust design, and superior operating comfort. Its single, multifunctional button is used to operate the measuring stroke and blow-out as well as eject the tip. Product features:Eppendorf "pipette/tip" system ensures utmost accuracy and precision. Ejection sleeve can be removed to fit into smaller vessels. Smooth-running piston is corrosion-free and chemically resistant . UV-resistant and completely autoclavable without any impairment of accuracy or precision.
Info Eppendorf North America
Customer Service: (800) 645-3050
Web site: http://www.eppendorfna.com/home/

Related medicine products :

1. Eppendorf Thermomixer
2. Eppendorf Thermomixer R
3. Eppendorf ThermoStat Plus, without block
4. Eppendorf Refrigerated Multipurpose Centrifuge Model 5804R
5. Eppendorf Refrigerated Multipurpose Centrifuge Model 5810R
6. Eppendorf Heat Sealing Film
7. Eppendorf heat sealing film
8. Eppendorf PCR film, self adhesive
9. Eppendorf Heat Sealing Foil
10. Eppendorf PCR foil, self adhesive
11. Eppendorf Sealing Mat 96
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
Medicine Products:
(Date:12/3/2008)...ific Gamma Imaging (BSGI) has,equivalent sensitiv...ents with,inconclusive findings after mammography..., according to findings presented today at the ann...America (RSNA). BSGI is a molecular breast,imagin...phy that can identify,lesions independent of tiss...
(Date:12/3/2008)...irstCall/ -- MAP,Pharmaceuticals, Inc. (Nasdaq: ...rticipate in a panel discussion titled "Adapting S... the 2008 RBC Capital Markets Healthcare Conferenc...T) in New York City. , A live webcast of th...or,Relations section of MAP Pharmaceuticals, webs...
(Date:12/3/2008)...thinner imported from China , , WEDNESDA...e deadly contamination of the blood thinner hepari...de chemical that was added to batches of the drug ..., The crisis, which began last November, resulted... in the United States. The Chinese heparin, contam...
(Date:12/3/2008)...The gold coin tradition continues for The Salvatio...d into the red kettles, with the first coin appear...$50 coin was wrapped in a $2 bill and deposited in... in Norridge. , , Since the first gold coin...ation Army has seen gold coins of every type and d...
Breaking Medicine News(10 mins):Health News:Molecular Breast Imaging Outperforms MRI for Patients With Inconclusive Results in the Diagnosis of Cancer 2Health News:Report Confirms Source of Contaminated Heparin 2Health News:Report Confirms Source of Contaminated Heparin 3
...ding to a new study from Columbia University rese...vement disorder, essential tremor (ET),// are more...healthy counterparts. Essential tremor is a disord...ieve it may be neurodegenerative in nature. The co...
...ding to a new study in the American Journal of Cli... play an important role in preventing the build up...vascular disease.// Research has shown antioxidant...ation of plaque in the arteries. However, most stu...
...ding to a notice distributed by the agency, the US...nited Therapeutics Corp.'s pulmonary arterial hype...A spokesperson for the FDA told Reuters Health tha... pulmonary arterial hypertension. The FDA approved...
...tists have ruled out a possible connection to auti...l Journal shows children with autism are no more l...stinal problems as infants. // Study investigators...children with autism and compared them to children...
Other Medicine News:
(Date:12/1/2008)...Dec. 2 New research has...lice computed tomography (CT) scanner in an emerge...stroke victims who receive a potentially life-savi...orth Shore Medical Center (NSMC)-Salem Hospital in...al meeting of the Radiological Society of North Am...
(Date:12/1/2008)..., Dec. 1 S*BIO Pte Ltd today annou...of SB1518, a potent and orally-active JAK2 inhibit...tients with chronic idiopathic myelofibrosis (CIMF...he safety and tolerability of SB1518 in patients w...s. The Phase 1 part of the study will assess the ...
(Date:12/1/2008)...tinence is still the best policy , , ROCHE...ew study from Mayo Clinic finds the use of the dru...olic hepatitis, an acute inflammation of the liver...esults of the study are published in the December ...rnal.org/ ). , , VIDEO ALERT: Additional a...
(Date:12/1/2008)...Dec. 1 GeoVax Labs, Inc....technology company developing,human vaccines for ...irus) and,other infectious agents, announced toda...rials will take place in twelve sites across North... collaboration with The National Institutes of,He...
Breaking Medicine Technology:Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3COX 2 expression is marker for cancer development in some benign breast biopsies 14088 1COX 2 expression is marker for cancer development in some benign breast biopsies 14088 2COX 2 expression is marker for cancer development in some benign breast biopsies 14088 3COX 2 expression is marker for cancer development in some benign breast biopsies 14088 4Mettler Toledo International Inc Announces Webcast of Presentation at Lehman Brothers Global Healthcare Conference 14086 1Zimmer Holdings to Present at Upcoming Investor Conferences 14084 1First early detection blood test for Parkinsons shows promise 14082 1First early detection blood test for Parkinsons shows promise 14082 2First early detection blood test for Parkinsons shows promise 14082 3
...007-Organon, the human,healthcare business unit of... Phase III clinical trials with corifollitropin al...e, have reached,their randomization target. , ,Co...hormone. It is,the first of a new class of gonadot...f which, due to its long half-life, one single,inj...
...)--Jun 27, 2007 - Annals of,Internal Medicine has ... on the impact of genistein on bone loss. The pape... Metabolism in Osteopenic,Postmenopausal Women-A R...ne 19, 2007) and details the safety and efficacy o...ia and,osteoporosis. The paper reports a significa...
Other Medicine Technology:Two Phase III clinical trials on corifollitropin alfa (Org 36286),reach randomization target 2Two Phase III clinical trials on corifollitropin alfa (Org 36286),reach randomization target 3New Proof of Genistein's Efficacy and Safety for Osteopenia and,Osteoporosis Published in Annals of Internal Medicine 2New Proof of Genistein's Efficacy and Safety for Osteopenia and,Osteoporosis Published in Annals of Internal Medicine 3